Viemed Healthcare (VMD) Stock Price, News & Analysis

Company Overview

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Key Stats

• Today's Range: $7.09 to $7.31
• 50-Day Range: $5.93 to $7.44
• 52-Week Range: $5.93 to $9.81
• Volume: 163,871 shs
• Average Volume: 176,591 shs
• Market Capitalization: $275.29 million
• P/E Ratio: 20.90
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VMD Stock Analysis - Frequently Asked Questions

How have VMD shares performed this year?

Viemed Healthcare's stock was trading at $8.02 on January 1st, 2025. Since then, VMD shares have decreased by 10.5% and is now trading at $7.18.

How were Viemed Healthcare's earnings last quarter?

Viemed Healthcare, Inc. (NASDAQ:VMD) released its quarterly earnings results on Wednesday, August, 6th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by $0.01. The firm earned $63.06 million during the quarter, compared to analyst estimates of $63.50 million. Viemed Healthcare had a trailing twelve-month return on equity of 10.38% and a net margin of 5.80%.
Read the conference call transcript.

Who are Viemed Healthcare's major shareholders?

Viemed Healthcare's top institutional investors include Forager Capital Management LLC (5.51%), Wasatch Advisors LP (3.99%), Kent Lake PR LLC (3.04%) and Geode Capital Management LLC (2.02%). Insiders that own company stock include Nitin Kaushal, Michael Moore, Randy E Dobbs, Jerome Cambre, Timothy Smokoff and Sabrina Heltz.
View institutional ownership trends.

How do I buy shares of Viemed Healthcare?

Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Viemed Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Viemed Healthcare investors own include Myomo (MYO), Cassava Sciences (SAVA), Alpha Teknova (TKNO), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Zevra Therapeutics (ZVRA) and Enterprise Products Partners (EPD).

Company Calendar

• Last Earnings: 8/06/2025
• Today: 8/25/2025
• Next Earnings (Estimated): 11/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:VMD
• CIK: 1729149
• Web: www.viemed.com
• Phone: (337) 504-3802
• Fax: N/A
• Employees: 1,179
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.34
• Trailing P/E Ratio: 21.12
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $11.27 million
• Net Margins: 5.80%
• Pretax Margin: 8.48%
• Return on Equity: 10.38%
• Return on Assets: 7.88%

Debt

• Debt-to-Equity Ratio: 0.02
• Current Ratio: 1.48
• Quick Ratio: 1.37

Sales & Book Value

• Annual Sales: $224.26 million
• Price / Sales: 1.24
• Cash Flow: $0.92 per share
• Price / Cash Flow: 7.77
• Book Value: $3.41 per share
• Price / Book: 2.11

Miscellaneous

• Outstanding Shares: 38,790,000
• Free Float: 31,029,000
• Market Cap: $278.51 million
• Optionable: Not Optionable
• Beta: 1.33